Doravirine, lamivudine, and tenofovir disoproxil fumarate
DELSTRIGO is a prescription medication combining doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg) in an oral tablet. It's used to treat HIV-1 infection in adults and children weighing at least 35 kg, working by inhibiting the virus's ability to replicate. Marketed by Merck Sharp & Dohme LLC since 2018. This information was generated using AI and is provided for informational and research purposes only.
Resources
1 resource available
-
Doravirine, lamivudine, and tenofovir disoproxil fumarate
TEXT/HTML
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | DELSTRIGO is a prescription medication combining doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg) in an oral tablet. It's used to treat HIV-1 infection in adults and children weighing at least 35 kg, working by inhibiting the virus's ability to replicate. Marketed by Merck Sharp & Dohme LLC since 2018. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Doravirine, lamivudine, and tenofovir disoproxil fumarate", "mediaType": "text/html", "description": " Access the FDA dataset for Doravirine, lamivudine, and tenofovir disoproxil fumarate — ANDA 210807 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210807" } ] |
| identifier | ANDA210807 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "fda", "medications", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Doravirine, lamivudine, and tenofovir disoproxil fumarate |
